Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article August 27 2025
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
Review Article August 26 2025
Platelet Heterogeneity: Variety Makes Immune and Vascular Function Better
Research Article August 26 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency
Review Article August 26 2025
Novel Strategies Targeting Mutant Calreticulin in Essential Thrombocythemia and Myelofibrosis
Research Article August 26 2025
LEF1 Intragenic Deletion Induces a Dominant-Negative isoform and unveils a Wnt/β3-Catenin Vulnerability in T-ALL
Research Article August 20 2025
Factor VIIa-released extracellular vesicles attenuate joint bleed-induced hemophilic arthropathy
Research Article August 19 2025
Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease
Review Article August 4 2025
How I Manage Chronic Myeloid Leukemia During Pregnancy
Review Article July 15 2025
The Treatment of Marginal Zone Lymphoma
Research Article July 10 2025
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens
Review Article May 15 2025
How I Evaluate and Treat Resistance and Relapse in CML
Review Article May 12 2025
How I approach hematopoietic stem cell transplantation for CML in a TKI world
Review Article April 16 2025
How I individualize treatment for chronic-phase CML
Review Article March 25 2025
How I treat chronic myeloid leukemia in children and adolescents
Page 3 of 3

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals